Item Type | Name |
Academic Article
|
Diagnostic codes associated with hypnotic medications during outpatient physician-patient encounters in the United States from 1990-1998.
|
Academic Article
|
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
|
Academic Article
|
Off-label prescribing in the treatment of dermatologic disease.
|
Academic Article
|
Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency.
|
Academic Article
|
Remissions of psoriasis with excimer laser treatment.
|
Academic Article
|
The design of clinical trials in psoriasis: lessons for clinical practice.
|
Academic Article
|
Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998.
|
Academic Article
|
Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States?
|
Academic Article
|
Case studies in severe psoriasis: A clinical strategy.
|
Academic Article
|
Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998.
|
Academic Article
|
Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians.
|
Academic Article
|
Efficacy is more easily assessed than safety.
|
Academic Article
|
Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
|
Academic Article
|
Over-the-counter topical skin products--a common component of skin disease management.
|
Academic Article
|
Determinants of quality of life in patients with psoriasis: a study from the US population.
|
Academic Article
|
The cost of psoriasis therapies: considerations for therapy selection.
|
Academic Article
|
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
|
Academic Article
|
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
|
Academic Article
|
Spanish dermatological vocabulary used by Mexican workers.
|
Academic Article
|
Inpatient management of severe psoriasis.
|
Academic Article
|
Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment.
|
Academic Article
|
Gel vehicles are not inherently more irritating than creams.
|
Academic Article
|
Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents.
|
Academic Article
|
Psoriasis treatment in the United States at the end of the 20th century.
|
Academic Article
|
Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
|
Academic Article
|
Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002.
|
Academic Article
|
What is the best approach to reducing birth defects associated with isotretinoin?
|
Academic Article
|
US dermatopathology fellows career survey: 2004-2005.
|
Academic Article
|
Comparison of different compliance behaviors in a clinical trial.
|
Academic Article
|
What you should do when people don't get well.
|
Academic Article
|
Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
|
Academic Article
|
Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
|
Academic Article
|
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
|
Academic Article
|
Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone.
|
Academic Article
|
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial.
|
Academic Article
|
The pharmacoeconomics of acne treatment: where are we heading?
|
Academic Article
|
Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis.
|
Academic Article
|
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
|
Academic Article
|
Increasing use of more potent treatments for psoriasis.
|
Academic Article
|
Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease.
|
Academic Article
|
Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data.
|
Academic Article
|
Health care utilization among migrant Latino farmworkers: the case of skin disease.
|
Academic Article
|
Drug Safety.
|
Academic Article
|
Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
|
Academic Article
|
Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
|
Academic Article
|
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
|
Academic Article
|
Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
|
Academic Article
|
Assessing adherence to dermatology treatments: a review of self-report and electronic measures.
|
Academic Article
|
Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
|
Academic Article
|
Placebo response?
|
Academic Article
|
Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg.
|
Academic Article
|
Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle.
|
Academic Article
|
Perhaps programs are a better way to go.
|
Academic Article
|
Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
|
Academic Article
|
Acitretin in dermatology: a review.
|
Academic Article
|
A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
|
Academic Article
|
How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis.
|
Academic Article
|
Usage of complementary and alternative medicine for management of skin disease.
|
Academic Article
|
Tattoo sites and psoriasis.
|
Academic Article
|
A review of protocols for 308 nm excimer laser phototherapy in psoriasis.
|
Academic Article
|
Letter: Tetracycline-induced hepatotoxicity.
|
Academic Article
|
Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
|
Academic Article
|
Trends in the use of topical over the counter products in the management of dermatologic disease in the United States.
|
Academic Article
|
Top dermatologic conditions in patients of color: an analysis of nationally representative data.
|
Academic Article
|
Treatment of impetigo: oral antibiotics most commonly prescribed.
|
Academic Article
|
Message from the guest editor.
|
Academic Article
|
JAK inhibitors in psoriasis: a promising new treatment modality.
|
Academic Article
|
Trends in older adult psoriasis outpatient health care practices in the United States.
|
Academic Article
|
Patient satisfaction with obstetricians and gynecologists compared with other specialties: analysis of US self-reported survey data.
|
Academic Article
|
Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
|
Academic Article
|
A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
|
Academic Article
|
Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data.
|
Academic Article
|
A systematic review of adverse effects associated with topical treatments for psoriasis.
|
Academic Article
|
The economic burden of skin disease in the United States.
|
Academic Article
|
The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
|
Academic Article
|
Electronic monitoring of medication adherence in skin disease: results of a pilot study.
|
Academic Article
|
Combination therapy to treat moderate to severe psoriasis.
|
Academic Article
|
Tacrolimus ointment: utilization patterns in children under age 2 years.
|
Academic Article
|
Medication and health care service utilization related to depressive symptoms in older adults with psoriasis.
|
Academic Article
|
Hyperpigmentation: a review of common treatment options.
|
Academic Article
|
Prescribing patterns for topical retinoids within NAMCS data.
|
Academic Article
|
Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.
|
Academic Article
|
The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis.
|
Academic Article
|
Healthcare utilization for acute and chronic diseases of young, school-age children in the rural and non-rural setting.
|
Academic Article
|
Biologic therapy for psoriasis: telephone triage.
|
Academic Article
|
Does the teratogenicity of isotretinoin outweigh its benefits?
|
Academic Article
|
Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
|
Academic Article
|
Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin.
|
Academic Article
|
The rise of the generic drug market and its implications for dermatology.
|
Academic Article
|
Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens.
|
Academic Article
|
Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States.
|
Academic Article
|
New treatments for psoriasis: which biologic is best?
|
Academic Article
|
Clobetasol propionate for psoriasis: are ointments really more potent?
|
Academic Article
|
Adherence in dermatology: a review of the last 20 years.
|
Academic Article
|
Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study.
|
Academic Article
|
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
|
Academic Article
|
Adapting electronic adherence monitors to standard packages of topical medications.
|
Academic Article
|
Prescribing on the basis of subjective disease severity.
|
Academic Article
|
Death from psoriasis: representative US data.
|
Academic Article
|
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
|
Academic Article
|
Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data.
|
Academic Article
|
Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis.
|
Academic Article
|
Misunderstandings.
|
Academic Article
|
Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
|
Academic Article
|
Adherence to topical therapy increases around the time of office visits.
|
Academic Article
|
Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review.
|
Academic Article
|
A method to gain a sense of relative efficacy of acne medications that have not yet been studied.
|
Academic Article
|
To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
|
Academic Article
|
Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
|
Academic Article
|
Photographic assessment of tretinoin microsphere gel in moderate acne.
|
Academic Article
|
The cost-effectiveness of rosacea treatments.
|
Academic Article
|
Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
|
Academic Article
|
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
|
Academic Article
|
Imiquimod: a review of basal cell carcinoma treatments.
|
Academic Article
|
Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
|
Academic Article
|
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
|
Academic Article
|
Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
|
Academic Article
|
Commentary on 'Indoor tanning injuries: an evaluation of FDA adverse event reporting data'.
|
Academic Article
|
Do topical retinoids cause acne to "flare"?
|
Academic Article
|
Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.
|
Academic Article
|
Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
|
Academic Article
|
Drug samples in dermatology: special considerations and recommendations for the future.
|
Academic Article
|
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
|
Academic Article
|
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
|
Academic Article
|
Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.
|
Academic Article
|
Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market.
|
Academic Article
|
Access to unused health care.
|
Academic Article
|
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.
|
Academic Article
|
Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.
|
Academic Article
|
Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
|
Academic Article
|
Is concomitant use of methotrexate and oral retinoids dangerous? A review of the data regarding this combination.
|
Academic Article
|
The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
|
Academic Article
|
How patients experience and manage dryness and irritation from acne treatment.
|
Academic Article
|
Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States.
|
Academic Article
|
Acitretin for the treatment of psoriasis: an assessment of national trends.
|
Academic Article
|
Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications.
|
Academic Article
|
Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
|
Academic Article
|
Topical drug delivery systems in dermatology: a review of patient adherence issues.
|
Academic Article
|
Side effects of common acne treatments.
|
Academic Article
|
Combination therapy in psoriasis: an evidence-based review.
|
Academic Article
|
Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
|
Academic Article
|
Psoriasis and cardiovascular screening rates in the United States.
|
Academic Article
|
Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis.
|
Concept
|
beta-Endorphin
|
Concept
|
Hydroxy Acids
|
Concept
|
Methylprednisolone
|
Concept
|
Urocanic Acid
|
Concept
|
Vitamin D
|
Concept
|
Pyridines
|
Concept
|
Emollients
|
Concept
|
Nonprescription Drugs
|
Concept
|
Drug Utilization Review
|
Concept
|
Triamcinolone Acetonide
|
Concept
|
Contraceptives, Oral
|
Concept
|
Suspensions
|
Concept
|
Injections, Intradermal
|
Concept
|
Drug Monitoring
|
Concept
|
Doxycycline
|
Concept
|
Drugs, Chinese Herbal
|
Concept
|
Clotrimazole
|
Concept
|
Cyanoacrylates
|
Concept
|
Agrochemicals
|
Concept
|
Antipsychotic Agents
|
Concept
|
Air Pollutants, Occupational
|
Concept
|
Oxymetazoline
|
Concept
|
Valine
|
Concept
|
Isotretinoin
|
Concept
|
Anesthetics, Local
|
Concept
|
Antiparasitic Agents
|
Concept
|
Hydroquinones
|
Concept
|
Receptors, Interleukin-12
|
Concept
|
Adamantane
|
Concept
|
Lidocaine
|
Concept
|
Zinc
|
Concept
|
Plant Extracts
|
Concept
|
Acrylic Resins
|
Concept
|
Interleukin-17
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Irritants
|
Concept
|
Detergents
|
Concept
|
Propiophenones
|
Concept
|
Immunoglobulin E
|
Concept
|
Histamine H1 Antagonists
|
Concept
|
Quinoxalines
|
Concept
|
Adrenal Cortex Hormones
|
Concept
|
Prednisone
|
Concept
|
Recombinant Fusion Proteins
|
Concept
|
Sodium Hypochlorite
|
Concept
|
Cyclosporine
|
Concept
|
Naphthalenes
|
Concept
|
Phosphoric Diester Hydrolases
|
Concept
|
Histamine Antagonists
|
Concept
|
Progestins
|
Concept
|
Antirheumatic Agents
|
Concept
|
Hydroxides
|
Concept
|
Desoximetasone
|
Concept
|
Allergens
|
Concept
|
Aminoquinolines
|
Concept
|
Cyclophosphamide
|
Concept
|
Betamethasone
|
Concept
|
Interleukin-12 Subunit p40
|
Concept
|
Dihydroxycholecalciferols
|
Concept
|
Tetracycline
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Sirolimus
|
Concept
|
Vitamin E
|
Concept
|
Interleukin-23
|
Concept
|
Phosphodiesterase Inhibitors
|
Concept
|
Drug Labeling
|
Concept
|
Drug Delivery Systems
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Vasodilator Agents
|
Concept
|
Antibodies
|
Concept
|
Drug Evaluation
|
Concept
|
Antineoplastic Agents
|
Concept
|
Metronidazole
|
Concept
|
Antiviral Agents
|
Concept
|
Mycophenolic Acid
|
Concept
|
Biological Products
|
Concept
|
Water
|
Concept
|
Photosensitizing Agents
|
Concept
|
Cinnamates
|
Concept
|
Drug Packaging
|
Concept
|
Interleukin-4
|
Concept
|
Fluocinolone Acetonide
|
Concept
|
Prescription Drugs
|
Concept
|
Excipients
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Hydrocortisone
|
Concept
|
Retinoids
|
Concept
|
Pyrimidines
|
Concept
|
Drug Interactions
|
Concept
|
Indicators and Reagents
|
Concept
|
Clobetasol
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Fluorouracil
|
Concept
|
Lipoxins
|
Concept
|
Small Molecule Libraries
|
Concept
|
Contraceptives, Oral, Combined
|
Concept
|
Etretinate
|
Concept
|
Keratolytic Agents
|
Concept
|
Vitamin A
|
Concept
|
Pyrroles
|
Concept
|
Antihypertensive Agents
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Anti-Infective Agents
|
Concept
|
Petrolatum
|
Concept
|
Estrogens
|
Concept
|
Nickel
|
Concept
|
Methotrexate
|
Concept
|
Chromium
|
Concept
|
Sunscreening Agents
|
Concept
|
Anti-Inflammatory Agents
|
Concept
|
Biological Factors
|
Concept
|
Isoniazid
|
Concept
|
Antimetabolites
|
Concept
|
Triamcinolone
|
Concept
|
Vidarabine
|
Concept
|
Drug Utilization
|
Concept
|
Interleukins
|
Concept
|
Drug Therapy, Computer-Assisted
|
Concept
|
Vasoconstrictor Agents
|
Concept
|
Chalcones
|
Concept
|
Boron Compounds
|
Concept
|
Antineoplastic Agents, Hormonal
|
Concept
|
Drug Administration Routes
|
Concept
|
Benzoyl Peroxide
|
Concept
|
Immunoglobulin G
|
Concept
|
Drug Resistance
|
Concept
|
Teratogens
|
Concept
|
Naltrexone
|
Concept
|
Thalidomide
|
Concept
|
Cytokines
|
Concept
|
Tacrolimus
|
Concept
|
Immunologic Factors
|
Concept
|
Anthralin
|
Concept
|
Dermatologic Agents
|
Concept
|
Minocycline
|
Concept
|
Receptors, Opioid, kappa
|
Concept
|
Drug Administration Schedule
|
Concept
|
Narcotics
|
Concept
|
Folic Acid
|
Concept
|
Pharmaceutical Preparations
|
Concept
|
Anti-Bacterial Agents
|
Concept
|
Selenium
|
Concept
|
Itraconazole
|
Concept
|
Fish Oils
|
Concept
|
Hydroxyurea
|
Concept
|
Botulinum Toxins
|
Concept
|
Interferon-gamma
|
Concept
|
Nicotine
|
Concept
|
Niacinamide
|
Concept
|
Adrenergic alpha-Agonists
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Minoxidil
|
Concept
|
Drug Compounding
|
Concept
|
Drug Eruptions
|
Concept
|
Ivermectin
|
Concept
|
Azetidines
|
Concept
|
Plasticizers
|
Concept
|
Drugs, Investigational
|
Concept
|
Interleukin-13
|
Concept
|
Drug Design
|
Concept
|
Drug Tolerance
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Drug Costs
|
Concept
|
Pyrazoles
|
Concept
|
Coal Tar
|
Concept
|
Narcotic Antagonists
|
Concept
|
Acitretin
|
Concept
|
Drug Approval
|
Concept
|
Antifungal Agents
|
Concept
|
Dicarboxylic Acids
|
Concept
|
Fluocortolone
|
Concept
|
Anti-Allergic Agents
|
Concept
|
Injections
|
Concept
|
Calcitriol
|
Concept
|
Interleukin-23 Subunit p19
|
Concept
|
Clindamycin
|
Concept
|
Antipruritics
|
Concept
|
Tretinoin
|
Concept
|
Hypnotics and Sedatives
|
Concept
|
Porphyrins
|
Concept
|
Drug Industry
|
Concept
|
Acyclovir
|
Concept
|
Folic Acid Antagonists
|
Concept
|
Drug Therapy
|
Concept
|
Drugs, Generic
|
Concept
|
Antimetabolites, Antineoplastic
|
Concept
|
Cholinergic Antagonists
|
Concept
|
Tetracyclines
|
Concept
|
Solutions
|
Concept
|
Fluocinonide
|
Concept
|
Receptors, Interleukin
|
Concept
|
Antitubercular Agents
|
Concept
|
Ketoconazole
|
Concept
|
Drug Resistance, Bacterial
|
Concept
|
Desonide
|
Concept
|
Interleukin-12
|
Concept
|
Azathioprine
|
Concept
|
Potassium Compounds
|
Concept
|
Risperidone
|
Concept
|
Glucocorticoids
|
Concept
|
Nicotinic Acids
|
Concept
|
Anesthetics, Combined
|
Concept
|
Dosage Forms
|
Concept
|
Epinephrine
|
Concept
|
Piperidines
|
Concept
|
Organometallic Compounds
|
Concept
|
Antigens, CD19
|
Concept
|
Sulfonamides
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Trifluoperazine
|
Concept
|
Receptors, Tumor Necrosis Factor
|
Concept
|
Ficusin
|
Concept
|
Salicylic Acid
|
Concept
|
Acrylates
|
Concept
|
Herpes Zoster Vaccine
|
Concept
|
Gels
|
Concept
|
Vitamins
|
Concept
|
Abnormalities, Drug-Induced
|
Concept
|
Cyclic AMP
|
Concept
|
Ointments
|
Concept
|
Drug Prescriptions
|
Concept
|
Drug Combinations
|
Concept
|
Erythromycin
|
Concept
|
Anti-Infective Agents, Local
|
Concept
|
Injections, Intravenous
|
Concept
|
Antidepressive Agents
|
Concept
|
Janus Kinases
|
Concept
|
Drug Storage
|
Concept
|
Flutamide
|
Concept
|
Herb-Drug Interactions
|
Academic Article
|
The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
|
Academic Article
|
Combination therapy for psoriasis in the United States.
|
Academic Article
|
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials.
|
Academic Article
|
Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
|
Academic Article
|
The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
|
Academic Article
|
Skin manifestations of outpatient adverse drug events in the United States: a national analysis.
|
Academic Article
|
Dermatologists' knowledge of and preferences regarding topical steroids.
|
Academic Article
|
Acitretin prescribing patterns in women of childbearing potential.
|
Academic Article
|
The continued evolution of drugs for psoriasis.
|
Academic Article
|
A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis.
|
Academic Article
|
Patterns of vitamin D analog use for the treatment of psoriasis.
|
Academic Article
|
Tachyphylaxis to topical glucocorticoids; what is the evidence?
|
Academic Article
|
Adherence to adalimumab in patients with moderate to severe psoriasis.
|
Academic Article
|
Adherence to ustekinumab in psoriasis patients.
|
Academic Article
|
Psoriasis treatments by payment type in the US outpatient office setting.
|
Academic Article
|
Dermatologist-diagnosed skin diseases among immigrant Latino poultry processors and other manual workers in North Carolina, USA.
|
Academic Article
|
Decreasing frequency of office visits on fridays.
|
Academic Article
|
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
|
Academic Article
|
Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
|
Academic Article
|
Improving medication adherence through technology: analyzing the managing meds video challenge.
|
Academic Article
|
Trends in sunscreen recommendation among US physicians.
|
Academic Article
|
Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis.
|
Academic Article
|
Patterns of ambulatory care usage and leading treatments for rosacea.
|
Academic Article
|
Treatment failure of patients using topical acne treatments: an observational retrospective cohort study.
|
Academic Article
|
Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review.
|
Academic Article
|
Current and future evidence-based acne treatment: a review.
|
Academic Article
|
Measure of atopic dermatitis disease severity using actigraphy.
|
Academic Article
|
Systemic therapies for psoriasis: an evidence-based update.
|
Academic Article
|
Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients.
|
Academic Article
|
Dyschromia in skin of color.
|
Academic Article
|
Principles of topical treatment: advancement in gel vehicle technology.
|
Academic Article
|
Trends in the outpatient medication management of lupus erythematosus in the United States.
|
Academic Article
|
Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease.
|
Academic Article
|
Assessing medication adherence using indirect self-report.
|
Academic Article
|
The duration of acne treatment.
|
Academic Article
|
Tolerability of topical antimicrobials in treatment of acne vulgaris.
|
Academic Article
|
The quality of life impact of acne and rosacea compared to other major medical conditions.
|
Academic Article
|
Surge in US outpatient vitamin D deficiency diagnoses: National Ambulatory Medical Care Survey analysis.
|
Academic Article
|
Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States.
|
Academic Article
|
Use of St. John's Wort in potentially dangerous combinations.
|
Academic Article
|
Underuse of early follow-up visits: a missed opportunity to improve patients' adherence.
|
Academic Article
|
Psoriasis: the new and the old.
|
Academic Article
|
Trends in systemic psoriasis treatment therapies from 1993 through 2010.
|
Academic Article
|
Rosacea: new and emerging treatments.
|
Academic Article
|
Trends in the Use of Neurotoxins and Dermal Fillers by US Physicians.
|
Academic Article
|
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
|
Academic Article
|
Emerging drugs for the treatment of acne.
|
Academic Article
|
The cost of biologics for psoriasis is increasing.
|
Academic Article
|
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
|
Academic Article
|
Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
|
Academic Article
|
Five-Year Trend in the Number of Dermatologic Clinical Drug Trials Registered on ClinicalTrials.gov.
|
Academic Article
|
Frequency of Primary Nonadherence to Acne Treatment.
|
Academic Article
|
Inflammatory diseases: Integrating biosimilars into clinical practice.
|
Academic Article
|
Assessment of rosacea severity: A review of evaluation methods used in clinical trials.
|
Academic Article
|
Trends in Ambulatory Health Care Usage for Adult Acne.
|
Academic Article
|
Cryo-Induced Thermal Wounds: A Human Acute Wound Model.
|
Academic Article
|
Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
|
Academic Article
|
New Frontiers in Psoriasis Treatment.
|
Academic Article
|
Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.
|
Academic Article
|
To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
|
Academic Article
|
Treatment of Alopecia Areata in the United States: A Retrospective Cross-Sectional Study.
|
Academic Article
|
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
|
Academic Article
|
The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.
|
Academic Article
|
Horrendous, Treatment-resistant Pediatric Atopic Dermatitis Solved With a Change in Vehicle.
|
Academic Article
|
Tazarotene foam, 0.1%, for the treatment of acne.
|
Academic Article
|
Costs of Common Psoriasis Medications, 2010-2014.
|
Academic Article
|
Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
|
Academic Article
|
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
|
Academic Article
|
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
|
Academic Article
|
Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
|
Academic Article
|
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
|
Academic Article
|
Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
|
Academic Article
|
First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs.
|
Academic Article
|
Current status and future prospects for biologic treatments of psoriasis.
|
Academic Article
|
A boxed warning for inadequate psoriasis treatment.
|
Academic Article
|
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
|
Academic Article
|
Adherence in dermatology.
|
Academic Article
|
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.
|
Academic Article
|
Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
|
Grant
|
Reinforcing Properties of UV Light in Tanning Bed Users
|
Academic Article
|
Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
|
Academic Article
|
Treatment of Atopic Dermatitis in the United States: Analysis of Data from the National Ambulatory Medical Care Survey.
|
Academic Article
|
Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.
|
Academic Article
|
Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial.
|
Academic Article
|
Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
|
Academic Article
|
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
|
Academic Article
|
An Anchoring-Based Intervention to Increase Patient Willingness to Use Injectable Medication in Psoriasis.
|
Academic Article
|
Nasal Valve Reconstruction Using a Titanium Implant: An Outcomes Study.
|
Academic Article
|
Real-world burden of comorbidities in US patients with psoriasis.
|
Academic Article
|
Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace.
|
Academic Article
|
Utility of boron in dermatology.
|
Academic Article
|
Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review.
|
Academic Article
|
Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.
|
Academic Article
|
Severe and acute complications of biologics in psoriasis.
|
Academic Article
|
A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation.
|
Academic Article
|
The safety of treatments used in pyoderma gangrenosum.
|
Academic Article
|
Six week evaluation of the potential for topical desoximetasone 0.25% spray to induce photoallergic skin reaction.
|
Academic Article
|
A safety review of the medications used to treat atopic dermatitis.
|
Academic Article
|
In-office compounding of lidocaine-epinephrine: An option for anesthesia preparation before skin biopsy.
|
Academic Article
|
Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne.
|
Academic Article
|
The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.
|
Academic Article
|
An assessment of the use of antihistamines in the management of atopic dermatitis.
|
Academic Article
|
Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
|
Academic Article
|
Adherence and resource use among psoriasis patients treated with biologics.
|
Academic Article
|
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
|
Academic Article
|
Patients preferences for different corticosteroid vehicles are highly variable.
|
Academic Article
|
Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012.
|
Academic Article
|
Characterization of Patients' Quality of Life and Experience in the Course of Acne Treatment.
|
Academic Article
|
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States.
|
Academic Article
|
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
|
Academic Article
|
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to Know.
|
Academic Article
|
Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
|
Academic Article
|
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.
|
Academic Article
|
Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroids.
|
Academic Article
|
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
|
Academic Article
|
Pharmacokinetics of tazarotene and acitretin in psoriasis.
|
Academic Article
|
Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
|
Academic Article
|
Topical corticosteroids for treatment-resistant atopic dermatitis.
|
Academic Article
|
The Challenge of Managing Atopic Dermatitis in the United States.
|
Academic Article
|
Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis
|
Academic Article
|
Tracking the price of existing biologics when drugs enter the market.
|
Academic Article
|
Relative efficacy of systemic treatments for atopic dermatitis.
|
Academic Article
|
A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data.
|
Academic Article
|
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
|
Academic Article
|
Tildrakizumab: A Review of Phase II and III Clinical Trials.
|
Academic Article
|
Is topical treatment effective for psoriasis in patients who failed topical treatment?
|
Academic Article
|
Topical Retinoids in Acne Vulgaris: A Systematic Review.
|
Academic Article
|
Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
|
Academic Article
|
The complexity of adverse event assessment and counseling for patients on biologic treatment.
|
Academic Article
|
The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment.
|
Academic Article
|
Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database.
|
Academic Article
|
Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray.
|
Academic Article
|
The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab.
|
Academic Article
|
Treatment patterns among patients with psoriasis using a large national payer database in the United States: a retrospective study.
|
Academic Article
|
The most common causes of burnout among US academic dermatologists based on a survey study.
|
Academic Article
|
Treatment Adherence and Persistence of Seven Commonly Prescribed Biologics for Moderate to Severe Psoriasis and Psoriatic Arthritis in a U.S. Commercially Insured Population.
|
Academic Article
|
Abametapir for the Treatment of Head Lice: A Drug Review.
|
Academic Article
|
An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne.
|
Academic Article
|
Confidence in Biosimilar Drugs is Not Much Improved by Framing Them as the "Gold" Alternative Treatment Option to Bio-originators.
|
Academic Article
|
Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study.
|
Academic Article
|
How the National Ambulatory Medical Care Survey has been used to identify health disparities in the care of patients in the United States.
|
Academic Article
|
Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation.
|